Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Construction method and application of caenorhabditis elegans hyperuricemia model and screening method of construction method

A technology of Caenorhabditis elegans and construction method, applied in the field of construction of high uric acid model of Caenorhabditis elegans, can solve problems such as high cost, unsuitable pathogenesis, and short maintenance time of high uric acid state

Inactive Publication Date: 2016-08-10
TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
View PDF2 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Different drug administration methods have their own advantages and disadvantages: the uneven food intake of feeding animals will make the blood uric acid level in the body unstable, but the duration is longer; intragastric administration can avoid the unstable blood uric acid level; injection is easy to operate, but The hyperuricemia state lasts for a short time, so it is not suitable for the study of pathogenesis; the combined administration of several methods is often effective, and the constructed hyperuricemia model has the characteristics of persistence and stability; the model mice established by gene knockout survived Short time, high cost
[0009] Through searching, there is no relevant report on the establishment of hyperuricemia model using Caenorhabditis elegans

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Construction method and application of caenorhabditis elegans hyperuricemia model and screening method of construction method
  • Construction method and application of caenorhabditis elegans hyperuricemia model and screening method of construction method
  • Construction method and application of caenorhabditis elegans hyperuricemia model and screening method of construction method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0118] Below in conjunction with embodiment, the present invention is further described; Following embodiment is illustrative, not limiting, can not limit protection scope of the present invention with following embodiment.

[0119] The raw materials used in the present invention, unless otherwise specified, are conventional commercially available products; the methods used in the present invention, unless otherwise specified, are conventional methods in the art.

[0120] The culture of C. elegans described in the present invention is uracil-deficient Escherichia coli (OP50).

[0121] The culture medium used by Caenorhabditis elegans in the present invention is a standard NGM medium.

[0122] 1 The relevant materials used in the present invention can be as follows:

[0123] 1.1 Materials: Caenorhabditis elegans.

[0124] 1.2 Solution preparation

[0125] Uric acid: Accurately weigh 15.0 mg of uric acid, add a small amount (50-300 μL) of DMSO to induce dissolution, take 15 m...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a construction method of a caenorhabditis elegans hyperuricemia model. The method comprises the following steps that 1, the uric acid content in caenorhabditis elegans is measured through a high performance liquid chromatography method; 2, an optimal drug delivery and culture mode is determined; 3, an optical drug delivery substance and drug delivery dosage are determined; 4, the optimal drug delivery time of xanthine is determined; 5, series experiment evaluation is conducted on the caenorhabditis elegans hyperuricemia model obtained through the construction method, and the caenorhabditis elegans hyperuricemia model which is low in damage, efficient, stable and reliable is obtained. According to the construction method, the hyperuricemia animal model is constructed by means of the model organism caenorhabditis elegans which has the high conservative property to human genes and has the similar uric acid metabolic pathway with human beings, the model has typical pathological characterization and is stable and reliable, various quantity indexes have the statistical significance, and a powerful tool is provided for large-scale and high-throughput drug screening of gout and the hyperuricemia symptom.

Description

technical field [0001] The invention belongs to the technical field of animal models of human chronic diseases, and relates to a method for establishing an animal model of human chronic diseases, in particular to a construction method and application of a Caenorhabditis elegans hyperuricemia model and a screening method for the construction method. Background technique [0002] With the improvement of people's living standards and changes in dietary structure, the incidence of hyperuricemia has been significantly increasing worldwide in recent years. Hyperuricemia itself not only poses a great threat to human health, but also produces various complications, such as cardiovascular and cerebrovascular diseases and atherosclerosis. Therefore, it has become an urgent task to strengthen the prevention and control of hyperuricemia and the research and development of related drugs. However, the lack of existing animal models of hyperuricemia has become a major obstacle in the path...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K49/00A61K31/522A61K31/52
CPCA61K31/52A61K31/522A61K49/0008Y02A50/30
Inventor 李贞景王昌禄李志熊春福陈勉华李风娟武淑芬
Owner TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products